Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- Combination Antifungal Therapy for Invasive Fungal Infections in Children and Adultson July 29, 2022 at 5:00 pm
In vitro studies Easily repeated, easily analyzed statistically, easily applied to multiple isolates, easy to study patterns of resistance ... Usually restricted to infections with uncommon ...
- Drug resistance to fungal infections increasing: ICMR reporton July 26, 2022 at 5:00 pm
There has been a sustained increase in drug-resistant pathogens ... The report further warned against a surge in fungal infections, including those due to rare species, among hospitalised patients.
- Biomarker-guided therapy for fungal sepsis produces no better outcomeson July 21, 2022 at 9:04 am
D-glucan as biomarker for invasive fungal infection in critically ill patients. The biomarker led to earlier and more frequent antifungal therapy but could not reduce mortality.
- Superbug infections spiked in pandemic's first waveon July 19, 2022 at 4:12 am
The first wave of the Covid pandemic created the perfect storm for superbugs in the U.S., with cases and deaths from dangerous drug-resistant bacterial and fungal infections spiking in hospitals ...
- Drug-Resistant Infections in Hospitals Soared During the Pandemic, C.D.C. Sayson July 13, 2022 at 1:44 pm
Deaths caused by infections impervious to antibiotics and antifungal medications rose ... increasing the chances for drug-resistant bugs to enter their bodies through intravenous lines, catheters ...
- CDC warns that prevalence of drug-resistant bacterial infections increased by up to 60% during the COVID-19 pandemic after years of declineson July 12, 2022 at 3:43 pm
The fungal infection, like many other drug resistant infections, can also spread through long-term healthcare facilities. 'A key finding was that C. Auris spreads mostly in long-term healthcare ...
- Covid set back progress on combating drug-resistant ‘superbugs’on July 12, 2022 at 3:31 pm
Many bacterial and fungal infections also went potentially undiagnosed and untreated during the pandemic, as many outpatient clinics closed or limited appointments, resulting in fewer in-person visits ...
- Drug-Resistant Infections And Deaths Among Hospital Patients Grew Amid Covid-19 Pandemicon July 12, 2022 at 3:39 am
Years of progress the United States had made in fighting drug-resistant infections were largely erased during the Covid-19 pandemic, with hospital-acquired infections and resulting deaths growing 15% ...
- The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotypeon May 31, 2021 at 6:05 am
The emergence of drug resistance in pathogenic microorganisms provides an excellent example of evolution that has had profound consequences for human health. As the evolution of drug resistance is ...
via Bing News